Drug pipeline to boost production
London - BioProcess UK recently presented initial results of an analysis of the upcoming bio-manufacturing needs of Great Britain. The study unveils that there are 50 UK companies with a total pipeline of 70 products in clinical trials and 4 in pre-registration. According to the analysis, up to 30 biologics could be approved over the next ten years. Therapeutic proteins make up about 60% of the pipeline.